Adsorption and emulsification properties of amphiphilic poly(styrene-co-octadecyl maleamic acid salt) with comb-like architecture

Multichain adsorption at fluid interfaces: Amphiphilic homopolymers vs copolymers

HYPOTHESIS

At selective liquid-liquid interface, amphiphilic homopolymers, having groups with different affinity for the liquids in each monomer unit, would demonstrate higher occupation of the interfacial layer than copolymers with various distributions of groups and be advantageous as interface stabilizers.

EXPERIMENTS

By means of Langevin dynamics computer simulation, conformations of multiple chains of amphiphilic macromolecules adsorbed at the liquid-liquid interface were studied. Monomer units having different affinity for the liquids were distributed variously along the polymer chains. Homopolymers, amphiphilic at the level of an individual monomer unit, and copolymers with random, altermating and multiblock distribution of groups were considered. The surface coverage, structure of the layer, and spatial distribution of monomer units were investigated depending on the polymer concentration.

FINDINGS

Compared to copolymers with random, alternating and multiblock distributions of the groups, the interfacial layer concentration of amphiphilic homopolymer is about 1.5 times higher, the adsorbed layer is remarkably thinner, has membrane-like structure and is asymmetric with respect to interface boundary. Also, the adsorbed amphiphilic homopolymers form fewer loops and tails, most located on one side of the interface. This combination of properties is promising for practical application in modern self-assembling molecular devices.

Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria

Cancer, malaria, and leishmaniasis remain the deadly diseases around the world although several strategies of treatment have been developed. However, most of the drugs used to treat the aforementioned diseases suffer from several pharmacological limitations such as poor pharmacokinetics, toxicity, drug resistance, poor bioavailability and water solubility. Artemisinin and its derivatives are antimalarial drugs. However, they also exhibit anticancer and antileishmanial activity. They have been evaluated as potential anticancer and antileishmanial drugs but their use is also limited by their poor water solubility and poor bioavailability. To overcome the aforementioned limitations associated with artemisinin and its derivatives used for the treatment of these diseases, they have been incorporated into nanoparticles. Several researchers incorporated this class of drugs into nanoparticles resulting in enhanced therapeutic outcomes. Their potential efficacy for the treatment of parasitic infections such as malaria and leishmaniasis and chronic diseases such as cancer has been reported. This review article will be focused on the nanoparticles formulations of artemisinin and derivatives for the treatment of cancer, malaria, and leishmaniasis and the biological outcomes (in vitro and in vivo).

An update on polymer-lipid hybrid systems for improving oral drug delivery

INTRODUCTION

A promising approach that has recently emerged to overcome the complex biobarriers and interrelated challenges associated with oral drug absorption is to combine the benefits of polymeric and lipid-based nanocarriers within one hybrid system. This multifaceted formulation strategy has given rise to a plethora of polymer-lipid hybrid (PLH) systems with varying nanostructures and biological activities, all of which have demonstrated the ability to improve the biopharmaceutical performance of a wide range of challenging therapeutics.

AREAS COVERED

The multitude of polymers that can be combined with lipids to exert a synergistic effect for oral drug delivery have been identified, reviewed and critically evaluated. Specific focus is attributed to preclinical studies performed within the past 5 years that have elucidated the role and mechanism of the polymer phase in altering the oral absorption of encapsulated therapeutics.

EXPERT OPINION

The potential of PLH systems has been clearly identified; however, improved understanding of the structure-activity relationship between PLH systems and oral absorption is fundamental for translating this promising delivery approach into a clinically relevant formulation. Advancing research within this field to identify optimal polymer, lipid combinations and engineering conditions for specific therapeutics are therefore encouraged.